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Abstract. Heme oxygenase (HO) is thought to be induced in severe malaria, but the pathophysiologic consequences
have not been examined. It is induced by hemolysis, oxidative stress, and inflammation. It degrades heme, producing
carbon monoxide (CO), which causes elevated levels of carboxyhemoglobin (COHb). In a prospective study of 1,520
children admitted to a Kenyan district hospital, COHb levels were no higher in children with malaria than with other
infections. The COHb levels in children with severe malarial anemia were higher than in other children with malaria, but
significantly lower than in children with other causes of severe anemia such as sickle cell disease. Levels of COHb were
not significantly higher in children with cerebral malaria or in those dying of malaria. These results do not support a
systemic increase in HO activity in malaria compared with other infectious diseases, but the roles of HO and CO in
malaria require further study.
INTRODUCTION
It has recently been reported that expression of heme oxy-
genase-1 (HO-1) is increased in individuals dying of Plasmo-
dium falciparum malaria.1–3 Heme oxygenase degrades heme,
producing biliverdin, iron, and carbon monoxide (CO), the
latter binding to hemoglobin to form carboxyhemoglobin
(COHb).4–6 Levels of COHb are raised in hemolytic diseases
such as sickle cell disease7,8 and were high in a single case of
cerebral malaria.9 The roles of HO-1 and CO are postulated
to be protective because they have potent anti-inflammatory
effects in diverse settings. Increased HO-1 expression reduces
heme-induced inflammation10; HO-1 activity and CO inhibit
the expression of lipopolysaccharide-induced pro-
inflammatory cytokines and promote the expression of anti-
inflammatory cytokines11,12; CO rescues lung from damage
by ischemia-reperfusion injury in HO-deficient mice;13 and
human HO deficiency is characterized by vulnerability to oxi-
dative and inflammatory damage,14 both of which occur in
children with severe malarial anemia.15,16 However, the for-
mation of COHb reduces the oxygen delivering capacity of
blood and may aggravate tissue hypoxia and acidosis seen in
severe malaria in children. Furthermore hemozoin, a polymer
of sequestered heme produced by P. falciparum, is resistant to
degradation by HO and may interfere with breakdown of
hemoglobin.17
To investigate the role of CO in P. falciparum malaria, we
measured concentrations of COHb in children admitted to
hospital with malaria, and compared them to children admit-
ted with other diseases and those who had recovered from
malaria.
MATERIALS AND METHODS
From June 2001 through November 2001, 1520 children
more than six months old were admitted to Kilifi District
Hospital. Kilifi is located on the coast of Kenya, where ma-
laria is holoendemic and almost exclusively caused by P. fal-
ciparum. The predominantly rural population of the area has
been described elsewhere.18 Ethical approval was obtained
from the Kenya Medical Research Institute ethics committee
and children participated in the study after informed consent
was obtained from a parent or guardian.
Demographic details, history, and examination findings by
a clinician from the Kenya Medical Research Institute were
recorded on a standardized proforma for all patients. Admis-
sion venous blood samples (prior to any blood transfusion)
were examined for malaria parasites (thick and thin films
stained with 10% Giemsa) and the number of pigment con-
taining cells was counted in each of 200 monocytes, neutro-
phils, and erythrocytes. A full blood count using a Coulter
Counter (MDII 18; Coulter Electronics, Ltd., Luton, United
Kingdom) and venous blood gas analysis for COHb, oxyhe-
moglobin (OxyHb), reduced hemoglobin (RHb), pH, and
base excess, using a co-oximeter (IL-682; Instrument Labora-
tory, Warrington, United Kingdom) were performed. Further
investigations including radiology, cerebrospinal fluid analy-
sis, bacterial cultures, repeat blood films, and hemoglobin
electrophoresis were performed as necessary to reach a pri-
mary diagnosis for each patient.
A diagnosis of malaria was only made in children with a
peripheral parasitemia and no other cause for the illness after
review of all clinical and laboratory data. Severe malaria was
defined as malaria with the presence of prostration, deep
breathing, or severe malarial anemia (hemoglobin level 5
g/dL). Cerebral malaria was defined by a Blantyre coma score
2 or inability to localize a painful stimulus.19 All children
were treated according to local guidelines.20 Additional diag-
noses such as anemia or febrile convulsions contributing to
the presentation, were recorded as secondary diagnoses.
An additional group of 50 children, who were well follow-
ing outpatient treatment with lapudrine and dapsone for mild
malaria, had hemoglobin and COHb concentrations mea-
sured at the same time that blood was taken on day 7 to
confirm clearance of parasitemia. These children did not have
quantitative assessment of malaria pigment on blood films.
Statistical analysis was performed using SPSS version 11.5
for the PC (SPSS, Inc., Chicago, IL). Central tendency for
normally distributed variables was expressed as mean with
standard deviation, and median with interquartile range for
non-normal distributions. Student’s t-test and one-way analy-
sis of variance were used to compare means. Kendall’s tau-b
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test (non-parametric) was used for all correlations. A P value
< 0.05 was considered significant. Further analysis to deter-
mine the effect of covariates on COHb was performed using
stepwise linear regression. The effect of dichotomous vari-
ables, adjusted for the influence of other fixed factors and
covariates, was assessed using general linear model regression
analysis. Covariates of interest were included in the first fit of
the model if significantly correlated with COHb (P < 0.10),
then excluded stepwise if they failed to have a significant
(P < 0.05) overall effect on the model.
RESULTS
Of 1,520 subjects, final diagnoses were available for 1,512,
of whom 850 (56.2%) had a diagnosis of malaria, 277 (18.3%)
had a diagnosis of anemia (Table 1), and 126 (8.3%) had
malaria with severe anemia. Some patients had more than
one diagnosis, giving a total of 2,124 diagnoses. In 1,477 chil-
dren (97.2%), the level of COHb was >2%; the maximum
reported for non-smokers in the United Kingdom.21 More
than 90% of the children were anemic (1,318 of 1,464 children
in whom hemoglobin concentration was measured; hemoglo-
bin level <11 g/dL in children <7 years old and <12 g/dL in
children 7 years old).
There were significant positive correlations between COHb
and age, spleen size, liver size, mean red blood cell volume,
OxyHb, pH, and base excess (Table 2). There were significant
inverse correlations between COHb and axillary tempera-
ture, white blood cell count, hemoglobin concentration, and
RHb. Although these correlations were statistically signifi-
cant, most of the correlation coefficients were very low, sug-
gesting that these factors explained little of the overall varia-
tion in COHb. Carboxyhemoglobin was not significantly as-
sociated with conscious level, capillary refill time, or the
proportion of malaria pigment−containing cells. Linear re-
gression analysis showed that there were significant indepen-
dent associations of COHb with age, hemoglobin concentra-
tion, mean red blood cell volume, pH, RHb, spleen size (all
P < 0.001), and liver size (P  0.007).
Mean COHb in children with malaria was not significantly
different from children with other primary diagnoses except
patients with sickle cell disease, in whom COHb was signifi-
cantly higher (Table 1). There was no significant difference in
mean levels of COHb in children with parasitemia on admis-
sion (n 894, mean 4.22%, SD 1.49%) compared with
those without parasitemia (n  568, mean  4.15%, SD 
1.57%). Malaria pigment was assessed in 1,481 subjects and
the mean COHb was not significantly different between those
with detectable pigment (n  652, mean  4.16%, SD 
1.29%) and those without (n  829, mean 4.25%, SD 
1.66%). The mean COHb was significantly (P < 0.001) higher
in subjects with severe anemia (n  208, mean  4.81%,
SD  1.76%) than in those without severe anemia (n 
1,256, mean  4.10%, SD  1.45%). Mean COHb in those
with a primary diagnosis of severe malarial anemia (n 109,
mean  4.43%, SD  1.51%) was significantly (P = 0.012)
lower than in those with severe anemia associated with other
primary diagnoses (n  67, mean  5.13%, SD  1.89%).
Mean COHb in jaundiced subjects (n  29, mean  5.52%,
SD 1.47%) was significantly (P  0.002) higher than in
those without jaundice (n  1,488, mean 4.19%, SD 
1.50%).
Malaria without other coexisting illness. Six hundred
eighty-nine patients had a primary diagnosis of malaria and
no other coexisting illness. Median age was 26 months (inter-
quartile range 16−42 months) and 668 (97.0%) had COHb
levels >2.0%. The mean hemoglobin concentration was 7.64
g/dL (SD  2.37) and 109 (16.3%) of 669 children were se-
verely anemic. In these children, COHb was significantly cor-
related with spleen size, oxyHb, mean cell volume, and pH
(all P < 0.001). There were inverse correlations of COHb with
temperature (P  0.044), RHb, hemoglobin concentration
(both P < 0.001), white blood cell count (P 0.008), and log
(parasite density) (P  0.033). There was no significant cor-
relation between COHb and age, liver size, capillary refill
time, conscious level, base excess, or proportion of pigment
containing neutrophils, monocytes, or erythrocytes. Stepwise
linear regression analysis showed that only hemoglobin con-
centration, mean red blood cell volume, RHb, and pH were
significantly (all P < 0.001) independently associated with
COHb. Only six children with a primary diagnosis of malaria
were jaundiced, with a mean COHb of 4.16% (SD 1.30%),
which was not significantly higher than in the other children
with malaria (n  681, mean  4.08%, SD  1.37%).
Severe malaria. The mean COHb of 4.31% (SD 1.42%)
in children with severe malaria was significantly higher (P
0.038) than in other children with malaria (n 566, mean
4.01%, SD  1.36). The independent associations of the dif-
ferent manifestations of severe malaria with COHb were
compared using general linear model regression analysis
(Table 3). Severe anemia was associated with a significantly
higher mean COHb and deep breathing was associated with a
significantly lower mean COHb. Mean levels of COHb in
those with prostration, cerebral malaria, or dying of malaria
were not significantly different from those in other children
with malaria.
Adjusted analysis. To confirm that differences in COHb
observed between groups were due to the diagnosis rather
than other factors, further analysis was performed to adjust
for the effect of significant laboratory and clinical variables.
The covariates included in each initial model were age, RHb,
mean cell volume, and pH. In models used to compare COHb
between groups with different manifestations of malaria, log
TABLE 1
Carboxyhemoglobin (COHb) levels in the most common
clinical diagnoses*
n†
Mean COHb
(95% CI)‡ SD P§
Malaria 850 (689) 4.08 (4.00–4.18) 1.44 –
Anemia 277 (33) 5.09 (4.43––5.75) 1.85 0.20
Gastroenteritis 181 (89) 3.83 (3.53–4.14) 1.37 1.00
LRTI 178 (93) 4.12 (3.84–4.40) 1.37 1.00
Malnutrition 150 (81) 4.05 (3.77–4.32) 1.24 1.00
Febrile convulsion 142 (15) 4.98 (4.14–5.82) 1.51 0.88
Sickle cell disease 32 (22) 6.56 (5.71–7.41) 1.91 < 0.001
PUO 29 (27) 4.15 (3.58–4.74) 1.48 1.00
Soft tissue infection 27 (14) 3.69 (3.03–4.34) 1.15 1.00
Burns 27 (25) 3.46 (3.02–3.90) 1.08 0.40
Epilepsy 24 (16) 5.09 (4.32–5.86) 1.44 0.54
* CI confidence interval; LRTI lower respiratory tract infection; PUO pyrexia of
unknown origin.
† Total. Values in parentheses are the number with a primary diagnosis only.
‡ For primary diagnosis only.
§ Compared with malaria by one-way analysis of variance using the post hoc Tamhane T2
test.
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(parasite density) was also included as a covariate. No adjust-
ment was made for hemoglobin concentration or spleen and
liver size because our hypothesis was that hemolysis would be
the main cause of any differences in COHb. Adjusted analysis
did not substantially change the results of any comparisons
made with univariate analysis. However, if adjustment was
also made for hemoglobin concentration, the mean COHb in
severe malaria was not significantly different from that in
other children with malaria, indicating that the degree of ane-
mia accounts for the difference between these groups.
Comparison with control children. In 50 well and apara-
sitemic children who had completed outpatient treatment of
mild malaria, the mean COHb was 1.13% (SD  0.73%),
which was significantly lower than in subjects admitted to
hospital with a primary diagnosis of malaria (P < 0.001). Only
4 (8%) of these children had COHb >2%. The mean hemo-
globin concentration was 9.71 g/dL and no children had se-
vere anemia. Carboxyhemoglobin was not significantly corre-
lated with hemoglobin concentration (r  -0.18, P  0.072).
DISCUSSION
Levels of COHb in this study of children admitted to a rural
Kenyan hospital were uniformly increased compared with
levels reported in studies of children and adults in the United
States and the United Kingdom, and levels in children who
had recovered from mild malaria. The mean COHb was 4.2%,
which was much higher than levels seen in American children
(range  0.6−3.9%, mean  1.3%) and healthy, non-
smoking, adults in the United Kingdom (mean ∼ 1%).7,21
However, within our study of inpatients, increased levels of
COHb were not associated with parasitemia or a primary
diagnosis of P. falciparum malaria, and this does not support
greater induction of systemic HO-1 activity in malaria com-
pared with other conditions. We were able to assess and ad-
just for the effect on COHb of a number of potentially im-
portant physiologic parameters, but in fact these had a neg-
ligible influence on the mean levels of COHb associated with
different illnesses.
There are a number of possible explanations for the high
overall levels of COHb in our population. Levels of COHb
are determined by both endogenous and exogenous sources
of CO,22 and environmental CO in smoke from traditional
cooking methods can lead to high levels of COHb,23 although
the levels were lower in children who had recovered from
mild malaria. In west African adults, COHb concentrations
even higher than those seen in our populations have been
reported.24 In this study, 90% of the children were anemic
and many children in this area of Kenya, even with iron de-
ficiency anemia, have evidence of hemolysis and dyserythro-
poiesis,25 both of which would be expected to increase endog-
enous CO production. The majority of our patients had in-
TABLE 3
Carboxyhemoglobin (COHb) levels associated with clinical features
in children with a primary diagnosis of malaria*
n
Mean (95% CI)
COHb SD P† P‡
Primary diagnosis of
malaria 689 4.08 (4.00–4.18) 1.44 – –
Any features of severe
malaria 123 4.31 (4.05–4.56) 1.42 – 0.012
Severe anemia 109 4.43 (4.15–4.72) 1.51 0.001 0.040
Deep breathing 50 3.82 (3.47–4.18) 1.26 0.002 0.021
Prostration 107 4.27 (3.98–4.56) 1.51 0.092 0.350
Cerebral malaria 58 4.17 (3.77–4.59) 1.57 0.792 0.503
Death 12 3.97 (3.00–4.93) 1.52 0.842 0.632
* CI  confidence interval.
† Using general linear model regression unadjusted for covariates.
‡ Using general linear model regression with initial covariates: age, temperature, reduced
hemoglobin concentration, mean cell volume, white cell count, log (parasite density),
and pH.
TABLE 2
Association of carboxyhemoglobin (COHb) with clinical and laboratory characteristics in univariate analyses*
n
Mean
(95% CI) SD Median
Interquartile
range (range)
Correlation
coefficient† P
Age (days) 1,520 739 440–1367 0.056 0.001
Temp (°C) 1,518 38.1 (38.0–38.1) 1.34 37.1–39.1 −0.043 0.014
Spleen (cm) 1,520 0 0–1 (0–20) 0.099 < 0.001
Liver (cm) 1,520 0 0–0 (0–10) 0.040 0.047
Capillary refill (sec) 1,520 1 0–2 (0–9) 0.005 0.79
BCS 1,520 5.00 5–5 (0–5) −0.10 0.63
COHb (%) 1,520 4.21 (4.13–4.29) 1.52 3.10–5.00 – –
RHb (%) 1,520 24.9 11.9–41.4 −0.316 < 0.001
OxyHb (%) 1,520 70.1 54.1–82.5 0.265 < 0.001
Hb (g/dL) 1,464 8.03 (7.90–8.15) 2.53 6.33–9.90 −0.172 < 0.001
MCV (fL) 1,463 70.4 (69.9–70.9) 10.1 63.1–76.2 0.096 < 0.001
WCC (109/L) 1,464 12.1 8.80–16.7 −0.065 < 0.001
Parasites (/L) 1,462 1,870 0–98,400 – –
Pigment-containing
neutrophils (/200) 1,479 0 0–2 (0–64) 0.004 0.853
Pigment-containing
monocytes (/200) 1,481 0 0–6 (0–79) −0.020 0.314
Pigment-containing
erythrocytes (/200) 1,474 0 0–0 (0–179) 0.016 0.446
BE (mEq/L) 1,467 −7.70 −10.9–5.50 0.045 0.012
pH 1,467 7.35 (7.34–7.35) 0.095 7.31–7.40 0.158 < 0.001
* n total number (for some subjects admission data on temperature, full blood count, parasite count, pH and base excess were unavailable); Cl confidence interval of mean; SD, standard
deviation; Temp axillary temperature on admission; Spleen/liver distance from palpable limit of organ to costal margin; BCS Blantyre Coma Score; RHb reduced hemoglobin; OxyHb
 oxyhemoglobin; MCV  mean cell volume; WCC  white cell count; BE  base excess.
† Using Kendall’s tau-b correlation.
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fectious illnesses requiring inpatient treatment and it is likely
that some of the increased CO production was associated with
sepsis.26 Although levels of COHb were not significantly dif-
ferent in patients with primarily non-infectious illnesses such
as epilepsy or burns, it is possible in some cases that infection
triggered seizures and that there was secondary infection or a
systemic inflammatory response associated with severe burns.
This perhaps explains why levels of COHb in children at the
end of outpatient treatment of mild malaria, without an active
systemic inflammatory response, were dramatically lower
than in any of the groups of inpatients.
In those with malaria, levels of COHb were not signifi-
cantly different from those with other infections such as lower
respiratory tract infection, gastroenteritis, and soft tissue in-
fections; results were compatible with malaria generating a
similar inflammatory response to other infections. Most of the
manifestations of severe malaria were not associated with sig-
nificantly different levels of COHb except for deep breathing,
in which lower levels of COHb were most likely as a result of
high ventilation rate,22 and severe anemia, where higher lev-
els were presumably due to hemolysis. However levels of
COHb seen in subjects with malaria, and even severe malarial
anemia, were considerably lower than in patients with sickle
cell disease where the mean COHb of 6.56% is similar to
values found in studies in the United States.8,27 This differ-
ence may be explained by the differences in hemolytic rate in
each condition. In adults with severe P. falciparum malaria,
the mean red blood cell lifespan has been shown to be ap-
proximately 40 days,28 which is substantially longer than in
sickle cell anemia where it may be only 10−20 days.29 The
finding of increased expression of HO-1 in the brains, lungs,
and livers of individuals dying of malaria1–3 does not prove
either systemic or local increases in HO-1 activity. It is pos-
sible for HO-1 to be induced but deprived of substrate, for
example by sequestration of heme as hemozoin, or even for
HO-1 activity to be inhibited. There is in vitro and in vivo
evidence that hemozoin is resistant to degradation by HO-1
and its presence reduces CO production in mice with ma-
laria.17,30 In our study, parasitemia was inversely correlated
with COHb in children with malaria, and we found no corre-
lation between COHb and circulating levels of malaria pig-
ment.
Any degree of reduction in HO-1 activity could be impor-
tant in the pathophysiology of malaria through loss of pro-
tection against oxidative damage, and loss of the anti-
inflammatory properties of CO. A relative deficiency of
HO-1 activity may contribute to the oxygen radical produc-
tion and oxidative stress which damages erythrocyte mem-
branes in severe malarial anemia.15,16 A reduction in CO pro-
duction may promote the inflammatory process in severe ma-
laria. It has recently been proposed that the combined action
of CO and nitric oxide may be important in the development
of tolerance to malaria by attenuating the systemic inflamma-
tory response.31 Insufficient CO production may shift the bal-
ance in favor of the inflammatory cascade.
In summary, this study suggests similar levels of HO activ-
ity in malaria to those seen in other infections, as measured by
levels of COHb. Systemic levels of COHb in humans may not
reflect CO production in individual tissues and further studies
are warranted to determine whether there is a relative reduc-
tion in HO activity in malaria, which may be of importance in
its pathogenesis.
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